Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
| Application |
Dilution |
| 1:1000-1:10000 |
Not tested in other applications.
Calculated MW
Positive Control
Molt-4 , mouse heart
Predict Reactivity
Rat, Bovine, Chicken, Pig, Xenopus laevis(>80% identity)
Form
Liquid
Buffer
0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
0.52mg/ml
Antigen Species
Human
Immunogen
Recombinant protein encompassing a sequence within the center region of human Myosin Light Chain 3. The exact sequence is proprietary.
Purification
Purified by antigen-affinity chromatography.
Conjugation
Unconjugated
Note
For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Synonyms
CMH8 antibody, MLC1SB antibody, MLC1V antibody, VLC1 antibody, MYL3 antibody, ventricular/slow twitch myosin alkali light chain antibody, myosin light chain 3 antibody, "myosin, light polypeptide 3, alkali, ventricular, skeletal, slow antibody", "myosin light chain 1, slow-twitch muscle B/ventricular isoform antibody", CMLC1 antibody, cardiac myosin light chain 1 antibody, "myosin, light chain 3, alkali, ventricular, skeletal, slow antibody"
Background
MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy. [provided by RefSeq]
Database
